| ||
Pharma Interest Group Meeting - May 2020Simulation of the Portfolio of COVID-19 VaccinesSpeakers: Vladimir Shnaydman and Jack ScannellMay 21, 2020 (Pharma Interest Group Meeting) Vladimir and Jack discuss the use of probabilistic approaches and simulation to explore the likelihood of success of COVID-19 vaccine development.
|